About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 639 record(s)
Req # A-2023-000513
The Drug and Health Product Register (DHPR) / Registre des médicaments et des produits de santé (RMPS) database in both official languages, particularly the contents related to the ingredients, side effects and description of the medication.Organization: Health Canada
July 2023
Req # A-2017-000315
The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for Avastin (Bevacizumab) by Hoffmann-La Roche Limited, Drug Identification Number (DIN): 02270994Organization: Health Canada
July 2023
Req # A-2018-001694
All records pertaining to the creation, and any subsequent revisions, of the "Thinking about banking your child’s cord blood".Organization: Health Canada
July 2023
Req # A-2019-001196
Regarding the safety review: "Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring Report a Concern Starting date: October 9, 2019. Posting date: October 9, 2019. The 10 incident reports, all the…Organization: Health Canada
July 2023
Req # A-2020-000296
All records regarding the rationale for why the restriction on the sale of alkyl nitrites was implemented. Information regarding the evidence that is being drawn upon to support it, from Janaury 1, 2011 to June 1, 2020.Organization: Health Canada
July 2023
Req # A-2020-001420
All communications sent/received by at officials the Director General (DG), Assitant Deputy Minister (ADM) or Deputy Minister (DM) level regarding the contract with BYD Canada Company Ltd.Organization: Health Canada
July 2023
Req # A-2021-000052
How many Canadian citizens in every province and terrirtory died specifically and only from Covid 19/Sars Cov2 without any other comorbities or health factors from August 2020 to March 2021. How many health effects or side effects from Canadian…Organization: Health Canada
July 2023
Req # A-2021-000869
Copy of all correspondence relating to complaints received regarding Computerixed Tomography (CT) Scans from January 2009 to August 25, 2021.Organization: Health Canada
July 2023
Req # A-2021-001621
Information about the Indigenous Navigator program that was stood up by Health Canada to enhance the services available to Indigenous applicants for cannabis licenses. Dates of interest would be 2017 to December 21, 2021.Organization: Health Canada
July 2023
Req # A-2022-000397
Any records the Registrant submitted in relation to the following applications: 2022-1039 (Reg. No. 21273), 2022-1040 (Reg. No. 21247) and 2022-1041 (Reg. No. 33125); any records provided by Health Canada and/or the Pest Management Regulatory Agency…Organization: Health Canada
July 2023